Cardiovascular and Renal Outcomes Among Kidney Transplant Recipients With Metabolic Syndrome: A Systematic Review and Meta‐Analysis
Clinical Transplantation · 2026-04 · 40 (4)
DOI: 10.1111/ctr.70519 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Transplantation, online erschienen am 31.03.2026. Verfasst von Min Yie Lim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia. Hauptthemen laut MEDLINE: Kidney Transplantation, Metabolic Syndrome, Cardiovascular Diseases, Graft Rejection. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben.
Abstract (Originalsprache)
Background
Kidney transplant recipients (KTRs) are at elevated risk for metabolic syndrome (MS), primarily due to the side effects of immunosuppressive therapy. Emerging evidence suggests that MS may be associated with adverse outcomes such as cardiovascular disease (CVD), reduced graft function, and graft loss. This review aims to evaluate the association between MS and cardio‐renal outcomes in KTRs, specifically its impact on the incidence of cardiovascular events, all‐cause mortality, graft failure, and acute graft rejection.
Methods
We conducted a comprehensive search in MEDLINE, EMBASE, and CENTRAL databases from inception to August 2024. No language restrictions were applied. Two reviewers independently screened articles, extracted data, and assessed study quality. Meta‐analyses were conducted using fixed‐effect or random‐effects models depending on heterogeneity. Effect estimates were reported as risk ratios (RRs) with 95% confidence intervals (CIs).
Results
Fifteen studies comprising a total of 8986 KTRs (3962 with MS and 5024 without MS) were included. Six studies reported major adverse cardiovascular events and all‐cause mortality, nine studies reported graft failure, and seven studies reported acute graft rejection. KTRs with MS had higher risk for major adverse cardiovascular events (RR 2.12, 95% CI: 1.32 to 3.41, p = 0.002), all‐cause mortality (RR 1.78, 95% CI: 1.21 to 2.62, p = 0.003), graft failure (RR 1.95, 95% CI 1.58 to 2.39, p < 0.00001) and acute graft rejection (RR 1.53, 95% CI 1.11 to 2.11, p = 0.009).
Conclusion
KTRs with MS are at significantly increased risk of adverse cardiovascular and renal outcomes. Further large‐scale prospective cohort studies using standardized definitions are needed to strengthen causal inference and guide clinical management in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
- Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
- Department of Anaesthesiology, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
- Department of Social & Preventive Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
- Nephrology Unit, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.
ORCID-Profile: Min Yie Lim, Loke Yuan Shee, Zhi Yong Wong, Wei Kei Wong, Ka Ting Ng, Foong Ming Moy, Soo Kun Lim
Zitieren
APA
Lim, M. Y., Shee, L. Y., Wong, Z. Y., Wong, W. K., Ng, K. T., Moy, F. M., & Lim, S. K. (2026). Cardiovascular and Renal Outcomes Among Kidney Transplant Recipients With Metabolic Syndrome: A Systematic Review and Meta‐Analysis. Clinical Transplantation, 40(4). https://doi.org/10.1111/ctr.70519
Vancouver
Lim MY, Shee LY, Wong ZY, Wong WK, Ng KT, Moy FM, et al. Cardiovascular and Renal Outcomes Among Kidney Transplant Recipients With Metabolic Syndrome: A Systematic Review and Meta‐Analysis. Clinical Transplantation. 2026;40(4). doi:10.1111/ctr.70519
BibTeX
@article{Lim2026,
author = {Lim, Min Yie and Shee, Loke Yuan and Wong, Zhi Yong and Wong, Wei Kei and Ng, Ka Ting and Moy, Foong Ming and Lim, Soo Kun},
title = {Cardiovascular and Renal Outcomes Among Kidney Transplant Recipients With Metabolic Syndrome: A Systematic Review and Meta‐Analysis},
journal = {Clinical Transplantation},
year = {2026},
volume = {40},
number = {4},
doi = {10.1111/ctr.70519}
}
EUVIMED